Whilst no specific human disease has been associated with mutations in RECQL5, polymorphisms have been associated with increased incidence of cancer in human populations (5,6), and knockout studies in mice show increased cancer susceptibility and greater incidence of double strand breaks and sister chromatid exchanges (7). Here, RECQL5 is linked to cancer.